Seroquel XR Sales Data
| Rank 46 | Current sales rank, all U.S. Pharmaceuticals. |
Last updated: February 2014 (updated quarterly).
The following data shows Seroquel XR U.S. retail sales in Q4 2013 compared to previous quarters.
| Date Range | Sales Rank | Sales ($000) | Units (000) | ||
|---|---|---|---|---|---|
| Q4 2013 | 46 ( 1) |
$291,494 | 2.22% | 378 | 0.80% |
| Q3 2013 | 47 ( 4) |
$285,176 | -5.86% | 375 | -6.72% |
| Q2 2013 | 43 (1) |
$302,919 | -0.49% | 402 | -0.99% |
| Q1 2013 | 44 | $304,400 | 6.81% | 406 | -4.69% |
| Q4 2012 | 44 (2) |
$284,989 | 0.24% | 426 | -0.93% |
| Q3 2012 | 46 (9) |
$284,299 | 6.05% | 430 | -0.46% |
| Q2 2012 | 55 (1) |
$268,071 | -5.08% | 432 | -3.79% |
| Q1 2012 | 54 (5) |
$282,416 | 7.81% | 449 | -2.18% |
| Q4 2011 | 59 (4) |
$261,947 | 2.27% | 459 | 2.00% |
| Q3 2011 | 55 (10) |
$256,141 | 2.65% | 450 | -1.96% |
| Q2 2011 | 65 (3) |
$249,529 | 2.86% | 459 | 3.85% |
| Q1 2011 | 68 | $242,586 | n/a | 442 | n/a |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
